Intravenous lidocaine infusion — a new treatment of chronic painful diabetic neuropathy?
- 1 January 1987
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pain
- Vol. 28 (1), 69-75
- https://doi.org/10.1016/0304-3959(87)91061-x
Abstract
In a randomized double-blind, cross-over study the effect of intravenous lidocaine (5 mg/kg body weight) on the symptoms and signs of painful diabetic neuropathy of more than 6 months duration has been evaluated. Using a clinical symptom scale, there was significant beneficial effect 1 and 8 days after lidocaine infusion compared to after saline infusion (P less than 0.05 and P less than 0.02, respectively). The duration of the individual effect ranged from 3 to 21 days. Lidocaine infusion had no effect on the objective measurements of neuropathy. Intravenous lidocaine infusion seems to be a new alternative treatment of chronic painful diabetic neuropathy.Keywords
This publication has 14 references indexed in Scilit:
- Treatment of chronic painful diabetic neuropathy with intravenous lidocaine infusion.BMJ, 1986
- Kinetics of Disopyramide after Intravenous Infusion to Patients with Myocardial Infarction and Heart FailureActa Pharmacologica et Toxicologica, 1985
- PAINFUL DIABETIC NEUROPATHYThe Lancet, 1985
- Imipramine treatment of painful diabetic neuropathyJAMA, 1984
- A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathyDiabetes, 1983
- Continuous Subcutaneous Insulin Infusion in the Management of Painful Diabetic NeuropathyDiabetes Care, 1982
- Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.Journal of Neurology, Neurosurgery & Psychiatry, 1981
- A Simple Test for Autonomic Neuropathy in Juvenile DiabeticsActa Medica Scandinavica, 1979
- Clinical Pharmacokinetics of LignocaineClinical Pharmacokinetics, 1978
- Intravenous Use of Xylocaine.*Anesthesia & Analgesia, 1951